Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

Benzer Materyaller

• Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes
  Yazar:: Masuda, Hiroko, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
  Yazar:: Yam, Clinton, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Effect of Metformin on Survival Outcomes in Diabetic Patients with Triple Receptor–Negative Breast Cancer
  Yazar:: Bayraktar, Soley, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
  Yazar:: Jose Rodrigo Espinosa Fernandez, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-01-01)
• Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research
  Yazar:: Espinosa Fernandez, Jose Rodrigo, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)